Furthermore, the breast tumor subtypes exhibit different forms of NF-κB activation, some associated with enhanced p50/RelA DNA binding, some with enhanced p50 or p52 DNA binding activity, some with enhanced c-Rel expression. This evidence concerns the gene RELA and breast neoplasm.